CC

Cornucopian Capital

Venture Capital · Private company

The healthspan-focused fund that led Ilant Health's $15 million Series A. Its partner's public forecast of a billion-dollar outcome is an investor's confidence, not a clinical result.

Latest on Cornucopian Capital

1 story

Sign up

Get your curated digest

After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio